Skip to content
Hi-Doctor

How to Get Mysimba Online in Utrecht

Understand why Mysimba is not currently available for prescription in Utrecht or the EU. This article explains its status and, more importantly, guides you to EU-approved, effective weight-loss treatments like Ozempic, Wegovy.

24 April 2026
How to Get Mysimba Online in Utrecht —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

Many patients in Utrecht, Netherlands, are searching for information on how to get Mysimba online for weight loss. It's important to clarify from the outset: Mysimba is currently not approved for weight-loss prescription in the EU, and Hi-Doctor does not offer it. While interest in modern weight-loss solutions is completely understandable, Mysimba is still in clinical development. This article will explain what Mysimba is, why it isn't a normal option yet, and critically, what proven, EU-approved weight-loss treatments you can access safely and legally through an EU-licensed doctor today.

What is Mysimba, and why isn't it a normal option yet?

Mysimba (also known as Amylin or cagrilintide) is an experimental peptide primarily known for its potential in weight management. It's designed as a GLP-1 receptor agonist, similar to some approved medications, but it also has amylin analogue properties, which could offer enhanced effects on satiety and blood sugar regulation. Currently, Mysimba is in various stages of clinical trials globally, evaluating its safety and efficacy. The European Medicines Agency (EMA) has not yet granted marketing authorization for Mysimba for weight loss. This means it cannot be legally prescribed or sold commercially in Utrecht or any other EU country. Seeking to acquire unapproved medications online carries significant health risks, including the danger of counterfeit products with unknown ingredients and dosages, and no medical oversight.

Proven weight-loss medications available online today

While Mysimba is not an option, several highly effective, EU-approved medications are available for weight loss when prescribed by a qualified doctor. These treatments have undergone rigorous testing and are proven to support significant weight reduction when combined with lifestyle changes.

  • Ozempic (semaglutide): Primarily for type 2 diabetes, doctors may prescribe it off-label for weight management in suitable patients, depending on individual assessment.
  • Wegovy (semaglutide): This is a higher-dose formulation of semaglutide, specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
  • Mounjaro (tirzepatide): A dual GIP and GLP-1 receptor agonist, Mounjaro is approved for type 2 diabetes and has shown significant weight loss benefits. Its use for weight management is expanding.
  • Saxenda (liraglutide): An earlier GLP-1 agonist, Saxenda is approved for weight management and is suitable for patients who meet specific criteria for obesity or overweight.

An EU-licensed doctor will assess your individual health profile to determine which, if any, of these medications is appropriate for you.

How to get a weight-loss prescription online in Utrecht, Netherlands

Accessing approved weight-loss medication through Hi-Doctor is a straightforward, secure, and medically sound process:

  1. Complete an online questionnaire: Spend 2-3 minutes providing your medical history and current health status through our secure platform.
  2. EU-licensed doctor reviews your case: An experienced Hi-Doctor physician, licensed within the EU, will carefully review your information to determine if a weight-loss treatment is safe and appropriate for you.
  3. Receive your REMPE prescription: If approved, you'll receive a valid REMPE electronic prescription (the Spanish standard, valid EU-wide) within 24 hours. This is delivered as a downloadable PDF to your private account and by email. If the doctor finds treatment is not appropriate, your €25 consultation fee is automatically refunded.
  4. Pick up at any EU pharmacy: Print your prescription or show it on your phone at any pharmacy in any EU country, thanks to the cross-border prescription directive 2011/24/EU.

The online consultation fee is a flat €25, with a money-back guarantee if treatment is not prescribed.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight-loss solutions, safety and efficacy must be paramount. Unregulated online peptide vendors or 'research chemical' sites offer products without medical oversight, quality control, or legal standing. Choosing Hi-Doctor ensures:

  • EU-licensed doctors: All consultations are conducted by medical professionals licensed to practice within the European Union.
  • Real medications, real pharmacies: You receive a legitimate prescription for EU-approved medications, dispensed by licensed pharmacies.
  • Auditable, RGPD-compliant chat: Your medical information and communication are secure and private, adhering to strict RGPD regulations.
  • Proven track record: With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor is a trusted name in online healthcare.

Avoid the risks associated with grey-market products and ensure your health is managed by qualified professionals.

COMMON QUESTIONS

Frequently asked questions

No, Mysimba is not legally approved for commercial sale or prescription in Spain or any other EU country for weight loss. It is still an investigational drug.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.